DNA methylation is an epigenetic modification in which methyl groups attach to cytosine bases in DNA — specifically at cytosine-guanine dinucleotide sites known as CpG sites. These modifications influence gene expression without altering the underlying DNA sequence, making them a dynamic and reversible record of cellular history.
How Methylation Changes With Age
As humans age, predictable and systematic changes occur in DNA methylation patterns across the genome. These changes are not random — they follow reproducible trajectories that are consistent across individuals and tissue types.
The discovery that methylation patterns change predictably with age — and that these changes can be used to estimate biological age — was one of the most significant breakthroughs in aging science of the past two decades.
Age-associated methylation changes influence:
- Chromatin structure — altering the accessibility of DNA to transcription factors
- Gene regulation — silencing tumor suppressor genes and activating inflammatory pathways
- Cellular function — contributing to cellular senescence and loss of tissue homeostasis
- Genomic stability — global hypomethylation increases genomic instability over time
From Methylation Patterns to Biological Age Estimates
Scientists discovered that by analyzing methylation levels across a selected set of CpG sites, it is possible to construct mathematical models that accurately estimate biological age. These models — called epigenetic clocks — use machine learning algorithms trained on large datasets of human tissue samples with known chronological ages.
The CpG Site Selection Process
Not all CpG sites change equally with age. Epigenetic clock researchers identify sites that show the most consistent, age-correlated methylation changes across diverse populations and tissue types. The Horvath clock, for example, uses 353 CpG sites selected from across the genome. More recent clocks such as GrimAge and PhenoAge use different site selections optimized for mortality and morbidity prediction respectively.
Accuracy and Validation
Epigenetic clocks have been validated in hundreds of independent studies. The correlation between predicted biological age and chronological age typically exceeds r = 0.95 in well-powered cohorts. More importantly, the deviation from predicted age — known as epigenetic age acceleration — is a stronger predictor of health outcomes than chronological age alone.
Why Methylation Outperforms Other Aging Biomarkers
Compared to other aging biomarkers, DNA methylation offers several distinct advantages:
- Multi-site integration — clocks aggregate signals from hundreds of CpG sites, reducing noise
- Tissue accessibility — methylation can be measured from blood, saliva, or biopsy samples
- Reversibility — methylation patterns respond to lifestyle and therapeutic interventions
- Predictive power — methylation clocks predict mortality, disease, and functional decline
- Reproducibility — results are consistent across laboratories using standardized platforms
XELGEN uses genome-wide methylation analysis to evaluate epigenetic biomarkers associated with aging. By analyzing methylation patterns across large CpG datasets using the Illumina Infinium EPIC array, the platform generates biological age estimates and aging biomarkers that help physicians monitor aging-related biological changes and evaluate the impact of clinical interventions.
Learn how XELGEN epigenetic testing measures DNA methylation across the genomeHow does DNA methylation measure biological aging?
DNA methylation patterns change systematically as people age. Scientists analyze methylation levels across CpG sites and use computational models called epigenetic clocks to estimate biological age with high accuracy.
